{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-040726","form_type":"8-K","ticker":"JAZZ","cik":"0001232524","company_name":"Jazz Pharmaceuticals plc","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.613997+00:00","generated_at":"2026-06-05T21:44:29.003101+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Jazz Pharmaceuticals names Philip Johnson as CFO, effective March 1, 2024","bullets":["Philip Johnson appointed EVP and CFO; succeeds Renée Galá who became President and COO in October 2023.","Johnson previously served as Group VP of Finance, Treasurer at Eli Lilly; over 35 years financial experience.","Annual base salary $700,000; target bonus 65% of salary; signing bonus $150,000.","New hire equity grant approximate value $4M, equal mix of restricted stock units and performance stock units."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-040726","json":"https://secwatch.observer/filing/0001193125-24-040726.json","markdown":"https://secwatch.observer/filing/0001193125-24-040726.md","text":"https://secwatch.observer/filing/0001193125-24-040726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/0001193125-24-040726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/d579255d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:44:29.003101+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53fb2178e6","claim":"Philip Johnson was appointed as Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals plc.","evidence_excerpt":"On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1232524/000119312524040726/0001193125-24-040726-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}